Cancer Communications Q1
Unclaimed
John Wiley & Sons Inc.
United Kingdom
Cancer Communications is a journal indexed in SJR in Oncology and Cancer Research with an H index of 94. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 6,403 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 6,403.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Cancer Research (Q1)
Oncology (Q1)
Price
1507 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
6,403
SJR Impact factor94
H Index100
Total Docs (Last Year)319
Total Docs (3 years)7285
Total Refs4682
Total Cites (3 years)180
Citable Docs (3 years)12.32
Cites/Doc (2 years)72.85
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
JAMA oncology Q1
Journal of Thoracic Oncology Q1
Cancer Discovery Q1
Neuro-Oncology Q1
Compare this journals
Aims and Scope
Cancer
Comments